malignancy
Conditions
Interventions
Index test:Al18F-NOTA-FAPI-04 PET/CT
Sponsors
Sichuan Cancer Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 100 Years
Inclusion criteria
Inclusion criteria: 1. Voluntary trial, with the patient or their legal representative signing an informed consent form; 2. Patient selection: Select patients who have been clinically diagnosed or diagnosed with malignant tumors in our hospital since November 22, 2023, and have complete clinical and follow-up data; 3. The criteria for diagnosing all subjects as malignant tumor patients are based on medical history, clinical manifestations, other imaging examinations such as X-rays, CT, MRI, and 18F-FDG PET-CT, and follow-up for more than 6 months.
Exclusion criteria
Exclusion criteria: 1. Individuals with a history of allergies to similar drugs (drugs with similar chemical or biological components to fibroblast activation protein inhibitors), allergic constitution, or current allergic diseases. 2. Those who are currently undergoing clinical trials of other drugs or have participated in clinical trials of any drugs (excluding vitamins and minerals). 3. There are other clinical problems that are difficult to control (such as HIV, hepatitis C virus infection or active hepatitis B, or other serious chronic infections and serious mental, neurological, cardiovascular, respiratory and other system diseases). 4. Pregnant and lactating women (where pregnancy is defined as a positive urine pregnancy test). 5. Patients whose physical condition is not suitable for radiation examination. 6. Researchers believe that exclusion is necessary.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Maximum standard uptake value ;mean standard uptake value ; | — |
Secondary
| Measure | Time frame |
|---|---|
| Tumor metabolic volume ;sensitivity;accuracy;specificity; | — |
Countries
China
Contacts
Public ContactZhuzhong Cheng
Sichuan Cancer Hospital
Outcome results
None listed